Viewing Study NCT01502605


Ignite Creation Date: 2025-12-25 @ 3:31 AM
Ignite Modification Date: 2026-01-09 @ 9:37 PM
Study NCT ID: NCT01502605
Status: TERMINATED
Last Update Posted: 2017-01-05
First Post: 2011-12-29
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Phase I Study of Orally Administered Aminolevulinic Acid for Resection of Malignant Astrocytomas
Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Astrocytoma View
None Glioma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None 5-ALA View
None Aminolevulinic Acid View
None Craniotomy View
None Brain Tumor View
None Surgical Resection View
None Neurosurgery View